#Medcrypt #Thirdwayv #Medical Cybersecurity

Strengthening Cybersecurity in Medical Devices

In an era where cybersecurity threats are increasingly looming over the healthcare landscape, the recent partnership between Thirdwayv Inc. and Medcrypt Inc. marks a significant leap forward. Announced during the Diabetes Technology Society Conference DTM 2025, this collaboration aims to advance standards and solutions for medical device interoperability and cybersecurity.

Both companies bring a wealth of knowledge and expertise to this partnership. Thirdwayv is recognized for its secure software solutions tailored for connected medical devices, while Medcrypt excels in cybersecurity and vulnerability management for the same sector. As the demand for strong cybersecurity measures escalates, especially in life-supporting devices, this collaboration is timely and vital.

Addressing Cybersecurity Challenges in Medical Devices

The constant proliferation of connected medical devices has introduced new complexities, including regulatory challenges and security vulnerabilities. With medical devices increasingly susceptible to cyber threats, ensuring their safety across their lifecycle is paramount. Together, Thirdwayv and Medcrypt will work to deliver integrated solutions that allow device manufacturers to embed security into the development process. This proactive approach can lead to better compliance and a safer user experience.

The partnership will focus on helping manufacturers maintain cybersecurity measures throughout the device lifecycle. This involves documenting cybersecurity controls and ensuring that these controls are adequately integrated into regulatory submissions. Additionally, the ability to deploy secure over-the-air (OTA) software updates for connected devices represents a crucial innovation.

The Strength of Combined Expertise

Each partner brings unique strengths to the table. The technology from Thirdwayv, including their secure connectivity and cryptographic identity Software Development Kits (SDKs), has been instrumental in implementing wireless cybersecurity for FDA-cleared connected diabetes management systems. Their expertise played a key role in the establishment of the IEEE 2621 standard, which promotes secure wireless connectivity for diabetes devices recognized by the FDA.

Complementing this, Medcrypt’s platform enables device manufacturers to assess and mitigate vulnerabilities while ensuring compliance with rapidly evolving global regulations. Their contributions to frameworks such as the Health Sector Coordinating Council's Joint Security Plan (JSP) offer critical insights into regulatory expectations and best practices for cybersecurity in the healthcare industry.

Pioneering End-to-End Compliance Solutions

The alliance between Thirdwayv and Medcrypt will result in a validated pathway for security and compliance tailored for medical device manufacturers. By aligning their efforts, the companies aim to accelerate time-to-market for life-saving technologies by reducing the risks associated with cybersecurity regulatory compliance.

As quoted by Medcrypt’s CEO, Mike Kijewski,